BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20065848)

  • 1. Comparison between conventional surgery plus postoperative adjuvant radiotherapy and concurrent chemoradiation for FIGO stage IIB cervical carcinoma: a retrospective study.
    Yamashita H; Okuma K; Kawana K; Nakagawa S; Oda K; Yano T; Kobayashi S; Wakui R; Ohtomo K; Nakagawa K
    Am J Clin Oncol; 2010 Dec; 33(6):583-6. PubMed ID: 20065848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1).
    Macchia G; Ferrandina G; Legge F; Deodato F; Ruggieri V; Lorusso D; Padula GD; Valentini V; Cellini N; Scambia G; Morganti AG
    Am J Clin Oncol; 2010 Dec; 33(6):577-82. PubMed ID: 20023568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for adjuvant hysterectomy after suboptimal concurrent chemoradiation in cervical carcinoma?
    Walji N; Chue AL; Yap C; Rogers LJ; El-Modir A; Chan KK; Singh K; Fernando IN
    Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):140-6. PubMed ID: 20045300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
    J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality approach in extra cervical locally advanced cervical cancer: chemoradiation, surgery and intra-operative radiation therapy. A phase II trial.
    Giorda G; Boz G; Gadducci A; Lucia E; De Piero G; De Paoli A; Innocente R; Trovò M; Sorio R; Campagnutta E
    Eur J Surg Oncol; 2011 May; 37(5):442-7. PubMed ID: 21492777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
    Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer.
    Mabuchi S; Okazawa M; Isohashi F; Matsuo K; Ohta Y; Suzuki O; Yoshioka Y; Enomoto T; Kamiura S; Kimura T
    Gynecol Oncol; 2011 Nov; 123(2):241-7. PubMed ID: 21820708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
    Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation break.
    Xu L; Pan J; Wu J; Pan C; Zhang Y; Lin S; Yang L; Chen C; Zhang C; Zheng W; Lin S; Ni X; Kong FM
    Radiother Oncol; 2010 Jul; 96(1):94-9. PubMed ID: 20435361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
    Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
    Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
    Ryu HS; Chun M; Chang KH; Chang HJ; Lee JP
    Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
    Kornovski Y; Gorchev G
    J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early stage cervical cancer: Brachytherapy followed by type a hysterectomy versus type B radical hysterectomy alone, a retrospective evaluation.
    Lacorre A; Merlot B; Garabedian C; Narducci F; Chereau E; Resbeut M; Minsat M; Leblanc E; Houvenaeghel G; Lambaudie E
    Eur J Surg Oncol; 2016 Mar; 42(3):376-82. PubMed ID: 26725307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma.
    Houvenaeghel G; Lelievre L; Gonzague-Casabianca L; Buttarelli M; Moutardier V; Goncalves A; Resbeut M
    Gynecol Oncol; 2006 Feb; 100(2):338-43. PubMed ID: 16213008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA.
    Kornovski Y; Gorchev G
    J BUON; 2006; 11(3):291-7. PubMed ID: 17309152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
    Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
    Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
    Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
    Int J Clin Oncol; 2016 Aug; 21(4):741-747. PubMed ID: 26857458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognosis analysis of 83 cases of cervical adenosquamous carcinoma].
    Yan M; Zhang YN; He JH; Huang H
    Ai Zheng; 2008 Sep; 27(9):956-61. PubMed ID: 18799035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-hysterectomy radiotherapy in FIGO stage IB-IIB uterine cervical carcinoma.
    Kim JH; Kim HJ; Hong S; Wu HG; Ha SW
    Gynecol Oncol; 2005 Feb; 96(2):407-14. PubMed ID: 15661229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.